These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Voltaren gel in the combined treatment of patients with psoriatic arthritis].
    Author: Shakhtmeĭster IIa, Kamennykh EV.
    Journal: Vestn Dermatol Venerol; 1990; (10):55-7. PubMed ID: 2278198.
    Abstract:
    One percent voltaren gel, a new drug manufactured by Ciba-Geigy [correction of Sib-Geigi], Switzerland, was used in the treatment of 57 patients with psoriasis in the progressive stage and psoriatic arthritis symptoms. The drug is characterized by antiinflammatory, analgesic, and antipyretic effects. No side effects or complications were recorded in the course of voltaren gel therapy. The drug has proved highly effective and is recommended for wide practice.
    [Abstract] [Full Text] [Related] [New Search]